European Pharmaceutical Review

FEBRUARY 22, 2023

1 Used to treat a range of chronic diseases (eg, diabetes, rheumatoid arthritis, psoriasis, Crohn’s disease, haemophilia, etc), it is projected that the sales of biologics will rise from $380 billion in 2022 to $416 billion in 2023, and to almost $600 billion in 2027. Caroline Peachey is Editor of European Pharmaceutical Review.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

Evolve Your Success

OCTOBER 31, 2023

Tune in and discover how one individual’s dedication can truly make a difference in the world of healthcare. It’s hard to divvy all that because we work with medical affairs and medical science liaisons. By 2027, they are projected to be about $10 billion. We have two managers.

Engineering 52

Engineering Sales Medical sales Medical 52

PM360

DECEMBER 12, 2024

In an insightful interview, leaders from the forefront of healthcare innovation Deepak Mittal , CEO of NextGen Invent ; Partha Anbil , SVP & Practice Leader at WNS Global; and Dr. William N. billion by 2027, growing at a CAGR of 25.8%. AI-based assistants have shown a significant impact on cancer care. Dr. William N.

Healthcare 52

Healthcare Healthcare Leads Medical 52